Susan Wolgamott
Family · Bloomfield Township, MINPI 1760894638
Payments from drug & device makers
Across 1,076 payments — averaging $304.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evoke Pharma, Inc.$91K
- AbbVie$72K
- Johnson & Johnson$56K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30K
- Lilly USA, LLC$21K
- Madrigal Pharmaceuticals$17K
- plus $40K from 25 others
What the payments were for
- Consulting fees$25,0788%
- Speaking & faculty fees$217,00566%
- Travel & lodging$61,52319%
- Food & beverage$22,4837%
- Education$1,1280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evoke Pharma, Inc. | 108 | $91,174 |
| AbbVie | 277 | $71,680 |
| Johnson & Johnson | 109 | $55,959 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 186 | $30,162 |
| Lilly USA, LLC | 60 | $20,733 |
| Madrigal Pharmaceuticals | 43 | $17,012 |
| Janssen Scientific Affairs, LLC | 19 | $12,706 |
| Ardelyx, Inc. | 44 | $9,611 |
| Nestle Healthcare Nutrition Inc. | 23 | $6,652 |
| E.r. Squibb & Sons, L.L.C. | 13 | $4,617 |
| Takeda Pharmaceuticals U.S.A., Inc. | 61 | $1,583 |
| Bristol Myers Squibb | 30 | $1,337 |
| Pfizer | 12 | $1,269 |
| Novo Nordisk | 1 | $928 |
| Gilead | 20 | $330 |
| Regeneron Healthcare Solutions, Inc. | 11 | $226 |
| Sanofi | 8 | $212 |
| QOL Medical, LLC | 14 | $177 |
| Merck | 9 | $160 |
| Exact Sciences | 2 | $123 |
| Boehringer Ingelheim | 1 | $111 |
| Intercept Pharmaceuticals, Inc. | 5 | $89 |
| Aimmune Therapeutics, Inc. | 5 | $80 |
| Ironwood Pharmaceuticals, Inc | 3 | $72 |
| Ipsen Biopharmaceuticals, Inc | 2 | $50 |
| Alnylam Pharmaceuticals Inc. | 3 | $50 |
| Ferring Pharmaceuticals Inc. | 3 | $46 |
| Braintree Laboratories, Inc. | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Mirum Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$327,216 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 11 | $288,975 |
| RinvoqUpadacitinib | 13 | $84,506 |
| LinzessLinaclotide | 121 | $78,396 |
| GimotiMetoclopramide Hcl | 28 | $59,552 |
| RezdiffraResmetirom | 13 | $51,523 |
| CreonLipase/Protease/Amylase | 11 | $50,997 |
| XifaxanRifaximin | 18 | $48,698 |
| IbsrelaTenapanor Hcl | 21 | $35,895 |
| MotegrityPrucalopride Succinate | 23 | $12,937 |
| Mesalamine | 15 | $7,791 |
| TrulancePlecanatide | 13 | $6,897 |
| Dexlansoprazole DrDexlansoprazole | 12 | $3,816 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 20 | $3,386 |
| Pantoprazole Sodium | 145 | $2,351 |
| CholestyramineCholestyramine (With Sugar) | 12 | $1,349 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $55,959 | $288,97511 claims |
| AbbVieRinvoq, Linzess, Creon | $71,680 | $213,899145 claims |
| Evoke Pharma, Inc.Gimoti | $91,174 | $59,55228 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $30,162 | $55,59531 claims |
| Madrigal PharmaceuticalsRezdiffra | $17,012 | $51,52313 claims |
| Ardelyx, Inc.Ibsrela | $9,611 | $35,89521 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $1,583 | $12,93723 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $46 | $3,38620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Bloomfield Township
- Jayme HeimGrandville$663K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
- Lane JudgeMonroe$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.